1. Home
  2. CNTB vs FEIM Comparison

CNTB vs FEIM Comparison

Compare CNTB & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • FEIM
  • Stock Information
  • Founded
  • CNTB 2012
  • FEIM 1961
  • Country
  • CNTB United States
  • FEIM United States
  • Employees
  • CNTB N/A
  • FEIM N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • FEIM Electrical Products
  • Sector
  • CNTB Health Care
  • FEIM Industrials
  • Exchange
  • CNTB Nasdaq
  • FEIM Nasdaq
  • Market Cap
  • CNTB 44.2M
  • FEIM 224.9M
  • IPO Year
  • CNTB 2021
  • FEIM N/A
  • Fundamental
  • Price
  • CNTB N/A
  • FEIM $22.51
  • Analyst Decision
  • CNTB Strong Buy
  • FEIM
  • Analyst Count
  • CNTB 2
  • FEIM 0
  • Target Price
  • CNTB $7.50
  • FEIM N/A
  • AVG Volume (30 Days)
  • CNTB 103.1K
  • FEIM 303.2K
  • Earning Date
  • CNTB 05-15-2025
  • FEIM 07-21-2025
  • Dividend Yield
  • CNTB N/A
  • FEIM 4.67%
  • EPS Growth
  • CNTB N/A
  • FEIM 604.98
  • EPS
  • CNTB N/A
  • FEIM 2.41
  • Revenue
  • CNTB $26,033,000.00
  • FEIM $65,400,999.00
  • Revenue This Year
  • CNTB N/A
  • FEIM N/A
  • Revenue Next Year
  • CNTB N/A
  • FEIM N/A
  • P/E Ratio
  • CNTB N/A
  • FEIM $8.88
  • Revenue Growth
  • CNTB N/A
  • FEIM 24.10
  • 52 Week Low
  • CNTB $0.51
  • FEIM $8.81
  • 52 Week High
  • CNTB $1.60
  • FEIM $24.77
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 72.64
  • FEIM 54.24
  • Support Level
  • CNTB $1.02
  • FEIM $20.34
  • Resistance Level
  • CNTB $1.07
  • FEIM $24.50
  • Average True Range (ATR)
  • CNTB 0.09
  • FEIM 1.56
  • MACD
  • CNTB 0.01
  • FEIM -0.10
  • Stochastic Oscillator
  • CNTB 91.19
  • FEIM 49.78

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

Share on Social Networks: